Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This was my question as well, how do the approval timeframes work
Naw, they haven’t posted nearly enough today to pay for cheeseburgers. Have you seen fast food prices?? Inflation ain’t no joke!
Where the ELTP cheeseburger posters at
No thanks
Doubtful
Too hot for that mess in late July, almost August. How many posts does it take to pay for A/C?
James, James, James.
Not an ELTP doom and gloom, sky-is-falling post? This is unacceptable.
Your company regularly goes through CFOs as well?
Say it louder
Post history tells me all I need to know. How long are you assigned here for?
Do you have evidence that that is not the case? Plausible either way.
But everyone knows the game now - I want cheap shares too.
Technically yes, but basically N/A unless you have a hand free for mouse/keyboard.
Takes time for the morning dose to kick in, be patient.
I’ll cheers to that.
Called in reinforcements lol
So pissed off when it’s down AND when it starts to go back up? I mean… Lol
It’s alive!
Not a ton of volume yet but the bids are steadily marching up this AM, encouraging.
I’ve been around a long time. It’s no secret any actual investor here is probably not thrilled with the stock price performance in the last many years. What difference does it make whether I’m happy with the CEO or not? I think he’s added a lot of fundamental value to the company itself compared to where we were. I think I’ve said on this board before that we need an actual IR department and strategy, not a PRN employee and bare minimum press releases, seems like. Also think a buyback would do wonders here.
I’d agree he’s done well and shareholder value has gone down/languished. However, the way he ends up making earth-shattering amounts of money, as the largest shareholder by far, is selling the company. Still have to ask yourself why he’d even care to accumulate so many shares if he didn’t believe they’d be worth much more in the future. He’s personally loaned the company money to help it grow as well - why do that if your ultimate goal is to buy the company cheap. Just let it basically fail, it’s literally less work than trying to grow the business.
Why hasn’t he already reverse split then if that’s the goal?
We theoretically have less fundamentals now than what he’s aiming for the future with a more solidified sales/marketing arm, and an additional facility to handle increased drug capacity, right?
As someone else essentially said, no one ever went broke taking some off the table. I don’t think that will be the peak either.
I’ve also learned in past trading that there is almost always a point where I can sell and make a profit from where I bought, it’s a question of how greedy do I want to be.
I agree that it’s worth the offer and then some.
What I’d like clarity on (did Nasrat clarify this?) is what are the timelines when you’ve had an existing ANDA filing already on the books (OxyContin generic) and it’s been in limbo pending supplementary info like the insufflation study/results? Once those are submitted, is it that 1-2 month window for another PDUFA date? So, hypothetically if results sent in 8/1/23, possible acceptance on 10/1/23, PDUFA date 8/1/24?
In other words, are we receiving zero benefit to the approval timeline from the Oxy ANDA itself having already been on file at the FDA for years now?
I misread it, thought they meant last fiscal year that just wrapped up. Can’t wait till Nasrat changes that stupid March fiscal year.
8-K out, accounting firm hired to audit last year’s financials through March
ITEM 4.01 CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT
On July 11, 2023, the Audit Committee of the Board of Directors (the "Audit Committee”) of Elite Pharmaceuticals, Inc. (the "Company”) approved the appointment, effective July 11, 2023, of Mazers USA LLP ("Mazers”) as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending March 31, 2024. The Audit Committee also dismissed Buchbinder Tunick & Company LLP ("Buchbinder”) as the Company’s independent registered public accounting firm, effective as of July 12, 2023.
What’s the alternative? Whine about Nasrat being the CEO? What would that do for me or anyone else?
Doesn’t seem like a great way to inspire confidence in other existing or new investors to buy ELTP shares either, so…
When the board does convert his salary to cash, do we know what the next ELTP talking point will be or has it not been issued yet? Not privy to what that memo schedule is. Daily, weekly?
Agree. Let’s keep expanding the pipeline, planning to expand the facility/purchase an additional facility, starting internal sales/marketing, on and on and on just to try and take the company private. Makes zero sense. It’s literally so much easier to do little to nothing and let the company flounder. Why personally loan the company your own money to keep it afloat/grow it? You wouldn’t if your ultimate goal was to buy it cheap.
But if that was true, why build the company up at all? Why personally loan them money to help stave off bankruptcy and/or to fuel growth? Just let it flounder and buy it up. Why do anything to potentially make that hostile takeover price higher?
If your theory was correct, why would Nasrat do anything at all to improve the value of the company? Why not just skip the sales and marketing altogether, just contract manufacture or something and that’s it? Make maybe 1-2 million a year in revenues, fire half the staff or more, let the stock drift as close to zero as possible as the company starts to appear “dead” or dying to the outside world and then scoop it up cheap.
He’s clearly not doing that as evidenced by building up sales and marketing division, planning for purchasing or otherwise acquiring additional facilities, continuing to fill the pipeline at all stages of product development and spending millions upon millions in R&D, mentioned possibly selling other companies’ products for additional income… if the stock price responded normally like other stocks do with positive fundamentals/developments, no one would be complaining.
It is indeed difficult for investors to purchase ELTP shares on a Saturday.
I think it’s safe to assume that when approved, generic Oxy will provide more than 3.8 cents to the bottom line.
The question is - is generic Oxy one of 3 the needle movers he mentioned?
Either way, I tend to agree with you. A dip to ~7 million in revenues from ~10 isn’t even terrible either, considering they are building up the sales arm from nothing at all.
I’m good with that. Not sure how feasible it is with current share count though.
No, no I don’t think I will.
Lol such a joke.
Only 1 business day left in that range, still confident??
ELTP the stock has been essentially disconnected from Elite the company, as far as performance goes. $30-40M in revenues now.
Gracias.
$ELTP$